ResearcherState Key Laboratory of ProteomicsActive in the last 2 years

Xiaoyu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-5006-175X; OpenAlex author ID A5100455533. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cell… Co-author DOI 10.1007/s13402-023-00856-z ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wantao Ying · 1 shared paper, 2024 · strength 0.23
- Paper Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-base… DOI 10.1007/s13402-023-00856-z ↗
Ran Kong · 1 shared paper, 2024 · strength 0.23
- Paper Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-base… DOI 10.1007/s13402-023-00856-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.